Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Abstract The synthetic tetrahydrocannabinol-analog nabilone improved non-motor symptoms (NMS) in Parkinson’s disease (PD) patients in a placebo-controlled, double-blind, parallel-group, randomized…